<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="109160">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01768364</url>
  </required_header>
  <id_info>
    <org_study_id>2012/953</org_study_id>
    <nct_id>NCT01768364</nct_id>
  </id_info>
  <brief_title>Antibiotic Prophylaxis When Removing Ureteric Stent After Stone Surgery</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tor Erik Sand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Akershus</source>
  <oversight_info>
    <authority>Norway: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Is there anything to gain in giving antibiotics as prophylaxis when removing ureteric stents
      cystoscopically after stone surgery?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Many patients undergoing stone surgery receive a ureteric stent that should be removed after
      14 days. This stent is removed cystoscopically and today this is done without giving
      antibiotics. Some patients get urinary tract infections subject to this. However the
      investigators do not know how many of these patients get UTI as most are followed by their
      primary care doctor. With this study the investigators would like to find out whether it is
      possible to avoid such infections and also find out how many actually do get infected.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>14 days infection rate w/wo antibiotics</measure>
    <time_frame>14 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>infection rate with ureter stent wo antibiotics</measure>
    <time_frame>14 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">124</enrollment>
  <condition>Ureteric Stent After Stone Surgery</condition>
  <arm_group>
    <arm_group_label>Antibiotics</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>will receive antibiotics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No antibiotics</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>will not receive antibiotics</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Trimetoprim-Sulfa (Bactrim)</intervention_name>
    <arm_group_label>Antibiotics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No antibiotics</intervention_name>
    <arm_group_label>No antibiotics</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stone surgery patients with ureteric stent that should be removed after 14 days

        Exclusion Criteria:

          -  ongoing antibiotic treatment, allergy to trimetoprim-sulfa
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tor Erik Sand, MD. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Akershus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tor Erik Sand, MD, PhD</last_name>
    <email>tor.erik.sand@ahus.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Manuela Estop-Garanto, MD</last_name>
    <email>mnet@ahus.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Akershus University Hospital</name>
      <address>
        <city>Lorenskog</city>
        <zip>1478</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Manuela Estop-Garanto, MD</last_name>
      <email>mnet@ahus.no</email>
    </contact>
    <contact_backup>
      <last_name>Tor Erik Sand, MD, PhD</last_name>
      <email>tor.erik.sand@ahus.no</email>
    </contact_backup>
    <investigator>
      <last_name>Tor Erik Sand, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 14, 2013</lastchanged_date>
  <firstreceived_date>January 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Akershus University College</investigator_affiliation>
    <investigator_full_name>Tor Erik Sand</investigator_full_name>
    <investigator_title>Professor, M.D., Ph.D.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
